1. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272.
Article
2. Chang S, Lim JH, Choi D, Park CK, Kwon NH, Cho SY, Choi DC. Hepatic visceral larva migrans of Toxocara canis: CT and sonographic findings. AJR Am J Roentgenol. 2006; 187:W622–W629.
3. Choi D, Lim JH, Choi DC, Lee KS, Paik SW, Kim SH, Choi YH, Huh S. Transmission of
Toxocara canis via ingestion of raw cow liver: a cross-sectional study in healthy adults. Korean J Parasitol. 2012; 50:23–27.
Article
4. Abdel Razek AA, Watcharakorn A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin N Am. 2011; 21:815–841.
Article
5. Jacquier P, Gottstein B, Stingelin Y, Eckert J. Immunodiagnosis of toxocarosis in humans: evaluation of a new enzyme-linked immunosorbent assay kit. J Clin Microbiol. 1991; 29:1831–1835.
Article
6. Kwon NH, Oh MJ, Lee SP, Lee BJ, Choi DC. The prevalence and diagnostic value of toxocariasis in unknown eosinophilia. Ann Hematol. 2006; 85:233–238.
Article
7. Dauriac-Le Masson V, Chochon F, Demeret S, Pierrot-Deseilligny C. Toxocara canis meningomyelitis. J Neurol. 2005; 252:1267–1268.
Article
8. Duprez TP, Bigaignon G, Delgrange E, Desfontaines P, Hermans M, Vervoort T, Sindic CJ, Buysschaert M. MRI of cervical cord lesions and their resolution in Toxocara canis myelopathy. Neuroradiology. 1996; 38:792–795.
Article
9. Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo. 2007; 49:279–287.
Article
10. Liao CW, Cho WL, Kao TC, Su KE, Lin YH, Fan CK. Blood-brain barrier impairment with enhanced SP, NK-1R, GFAP and claudin-5 expressions in experimental cerebral toxocariasis. Parasite Immunol. 2008; 30:525–534.
Article
11. Kim YB, Ko YC, Jeon SH, Park HM, Shin WC, Lee YB, Ha KS, Shin DJ, Lim YH, Ryu JS, Chung MS. Toxocariasis: an unusual cause of cerebral infarction. J Korean Neurol Assoc. 2003; 21:651–654.
12. Han WH, Kim JE, Do JK, Jung BW, Kwon HH. Cerebral infarctions associated with toxocariasis-induced secondary hypereosinophilia. Korean J Stroke. 2010; 12:109–111.
13. Xinou E, Lefkopoulos A, Gelagoti M, Drevelegas A, Diakou A, Milonas I, Dimitriadis AS. CT and MR imaging findings in cerebral toxocaral disease. AJNR Am J Neuroradiol. 2003; 24:714–718.
14. Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke. 1984; 15:221–223.
Article
15. Grigoryan M, Geisler SD, St Louis EK, Baumbach GL, Davis PH. Cerebral arteriolar thromboembolism in idiopathic hypereosinophilic syndrome. Arch Neurol. 2009; 66:528–531.
Article
16. Prick JJ, Gabreëls-Festen AA, Korten JJ, van der Wiel TW. Neurological manifestations of the hypereosinophilic syndrome. Clin Neurol Neurosurg. 1988; 90:269–273.
17. Vidal JE, Sztajnbok J, Seguro AC. Eosinophilic meningoencephalitis due to
Toxocara canis: case report and review of the literature. Am J Trop Med Hyg. 2003; 69:341–343.
Article
18. Jung H, Hurtado M, Medina MT, Sanchez M, Sotelo J. Dexamethasone increases plasma levels of albendazole. J Neurol. 1990; 237:279–280.
Article